Current Medicinal Chemistry

Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions
pp. 1587-1601(15)
Authors: Gentilucci, L.; Tolomelli, A.; De Marco, R.; Artali, R.

Converting Peptides into Drug Leads by Lipidation
pp. 1602-1618(17)
Authors: Zhang, L.; Bulaj, G.

Ion Pore Formation in Lipid Bilayers and Related Energetic Considerations
pp. 1619-1634(16)
Authors: Ashrafuzzaman, Md.; Tuszynski, J.

Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti- Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design
pp. 1635-1645(11)
Authors: Speck-Planche, A.; Luan, F.; N.D.S. Cordeiro, M.

Molecular Property Filters Describing Pharmacokinetics and Drug Binding
pp. 1646-1662(17)
Authors: T. Garcia-Sosa, A.; Maran, U.; Hetenyi, C.

Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
pp. 1663-1681(19)
Authors: R. Neves, A.; Lucio, M.; L.C. Lima, J.; Reis, S.

Chemical Metabolism of Medicinal Compounds from Natural Botanicals
pp. 1682-1705(24)
Authors: Lu, Q.; Jiang, J.-G.

Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
pp. 1706-1720(15)
Authors: M. Varoni, E.; Lodi, G.; Sardella, A.; Carrassi, A.; Iriti, M.

In Vitro - In Vivo Correlation of Gene Expression Alterations Induced by Liver Carcinogens
pp. 1721-1730(10)
Authors: Heise, T.; Schug, M.; Storm, D.; Ellinger-Ziegelbauer, H.; J. Ahr, H.; Hellwig, B.; Rahnenfuhrer, J.; Ghallab, A.; Guenther, G.; Sisnaiske, J.; Reif, R.; Godoy, P.; Mielke, H.; Gundert-Remy, U.; Lampen, A.; Oberemm, A.; G. Hengstler, J.

Nonmuscle Myosin Heavy Chain and Histone H3 are Intracellular Binding Partners of Lithospermic Acid B and Mediate its Antiproliferative Effect on VSMCs
pp. 1731-1737(7)
Authors: H. Cho, Y.; Y. Lim, E.; M. Kim, J.; Jung, M.; C. Lee, H.; Seo, M.; J. Lee, E.